1. Name and Address of Reporting Person*
222 BERKELEY STREET |
SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
222 BERKELEY STREET |
SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
222 BERKELEY STREEY |
SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
C/O OXFORD BIOSCIENCE PARTNERS IV, L.P. |
222 BERKELEY ST., SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
X |
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
C/O OXFORD BIOSCIENCE PARTNERS IV, L.P. |
222 BERKELEY ST., SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
C/O OXFORD BIOSCIENCE PARTNERS IV, L.P. |
315 POST RD. WEST |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
C/O OXFORD BIOSCIENCE PARTNERS IV, L.P. |
222 BERKELEY ST., SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
C/O OXFORD BIOSCIENCE PARTNERS IV, L.P. |
222 BERKELEY ST., SUITE 1650 |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
|
Jonathan Fleming, as general partner of the general partner of Oxford Bioscience Partners IV L.P. |
11/08/2004 |
|
Jonathan Fleming, as general partner of the general partner of mRNA Fund II L.P. |
11/08/2004 |
|
Jonathan Fleming, as general partner of OBP Management IV L.P. |
11/08/2004 |
|
Jonathan Fleming |
11/08/2004 |
|
Raymond Charest, as attorney-in-fact for Mark P. Carthy |
11/08/2004 |
|
Raymond Charest, as attorney-in-fact for Alan Walton |
11/08/2004 |
|
Jeffrey T. Barnes |
11/08/2004 |
|
Michael Lytton |
11/08/2004 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |